Enlivex Therapeutics Ltd. Quarterly Common Stock, Shares, Outstanding from Q4 2013 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Enlivex Therapeutics Ltd. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2013 to Q2 2024.
  • Enlivex Therapeutics Ltd. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 20.9M shares, a 12.3% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 20.9M +2.29M +12.3% Jun 30, 2024 6-K 2024-08-30
Q4 2023 18.6M +177K +0.96% Dec 31, 2023 6-K 2024-08-30
Q2 2023 18.6M +208K +1.13% Jun 30, 2023 6-K 2023-09-01
Q4 2022 18.4M +90.3K +0.49% Dec 31, 2022 20-F 2024-04-30
Q2 2022 18.4M +74.9K +0.41% Jun 30, 2022 6-K 2022-08-22
Q4 2021 18.3M +3.74M +25.7% Dec 31, 2021 20-F 2023-04-10
Q2 2021 18.3M +7.97M +77.1% Jun 30, 2021 6-K 2021-08-06
Q4 2020 14.6M +4.25M +41.2% Dec 31, 2020 20-F 2022-04-29
Q2 2020 10.3M Jun 30, 2020 6-K/A 2020-10-13
Q4 2019 10.3M +6.82M +194% Dec 31, 2019 20-F 2021-04-30
Q4 2018 3.51M +3.09M +739% Dec 31, 2018 20-F 2020-04-30
Q4 2017 418K -2.86M -87.2% Dec 31, 2017 20-F/A 2020-01-23
Q4 2016 3.28M -11M -77% Dec 31, 2016 20-F 2018-04-23
Q4 2015 14.2M 0 0% Dec 31, 2015 20-F 2017-02-24
Q4 2014 14.2M +5.05M +55% Dec 31, 2014 20-F 2016-03-29
Q4 2013 9.18M Dec 31, 2013 20-F 2015-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.